DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Emerging Therapies

Track performance, prescriber and non-prescriber insights on uptake of key new drugs and the impact on market dynamics in three waves post-launch

  • Anticipate the potential impact on current brands to inform product launch strategies
  • Benchmark your drug’s uptake against comparable past launches
  • Determine which factors drive product awareness and optimize your strategies to protect market share or maximize the impact of new product launches
  • Analyze the impact of face-to-face detailing with physicians to enhance marketing strategies

 

Schedule a demo

Methodology

  • Primary market research with U.S. physicians based on analyst-written surveys, including 75 specialists per wave
  • Three-wave series of analysis at one, six, and twelve-months post-commercial launch